Cytotoxic Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Cytotoxic Drugs Market By Product Type (Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids, and Others), Route of Administration (Oral and Parental), Application (Breast Cancer, Prostate Cancer, Lung Cancer, Pancreatic Cancer, and Others), End User (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Cytotoxic Drugs Market size is expected to be valued at USD 15,927.2 million in 2022, growing at a significant CAGR of 2.2% during 2022–2028. Cytotoxic drugs, also known as antineoplastics, are a group of medicines that contain toxic chemicals to cells, preventing their replication or growth. They are widely used to treat various cancers and other disorders, such as rheumatoid arthritis and multiple sclerosis. Cytotoxic drugs can destroy tumors and reduce metastases and lessen cancer symptoms. Cancer cells replicate faster than normal cells, making them susceptible to cytostatics. The effects on normal cells are less pronounced, and healthy cells recover faster. The increasing prevalence of various types of cancer, such as leukemia, breast cancer, etc, is the major driver in the global cytotoxic drugs market growth. According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The most common cancer in 2020 was breast cancer (2.26 million cases), lung (2.21 million cases), etc. Moreover, increasing use and approval of cytotoxic drugs are also expected to boost the global cytotoxic drugs market growth. Also, the growing therapeutic area of cytotoxic drugs in auto-immune conditions such as rheumatoid arthritis, psoriasis, or prevention of transplant rejection is influencing the overall cytotoxic market growth. However, the adverse side effects of the consumption of cytotoxic drugs, such as nausea and vomiting, severe diarrhea, and damage to normal cells and tissue, are restraining the global cytotoxic drugs market growth. Based on the product type, the global cytotoxic market is segmented into alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others. The antimetabolites segment held the major global cytotoxic drugs market revenue in 2021. Geographically, North America held the major market share in the global cytotoxic drugs market and is expected to dominate the global market in the forecasted years.

Recent Market Developments:

In Sept 2022, FDA cleared AstraZeneca’s Imfinzi to treat locally advanced or metastatic biliary tract cancer, making it the first immunotherapy-based treatment option for this aggressive cancer type.

In May 2022, Pfizer announced Asia’s first global drug development center at IIT Madras Research Park.

Cytotoxic Drugs Market

MARKET SUMMARY
-
2.2%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 2.2%
  • Largest Market– Asia Pacific
  • Fastest Growing Market–  North America

Cytotoxic Drugs Market

  • The cytotoxic drugs market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The cytotoxic drugs market is segmented based on based on product type, route of administration, application, end-user, and geography.
Key Players
  • Pfizer Inc.
  • AbbVie Inc.
  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
Cytotoxic Drugs Market Dynamics

The surging number of cancer patients worldwide boosts the global cytotoxic market growth. It is mainly attributed to the increasing number of cigarette smokers and secondary smoke exposure, exposure to sun and tanning beds, overweight and obesity, excessive alcohol use, and various infectious disease. According to the National Cancer Institute, around 1,806,590 new cancer cases are diagnosed in the United States. Therefore, the adoption of cytotoxic chemotherapy drugs is expected to boost the global cytotoxic drugs market growth at a significant rate.


North-America Got Significant Share

Cytotoxic Drugs Market

The market share is divided into North America, Asia-pacific, Europe, the Middle East, and the African region. The cytotoxic drugs market in the Asia Pacific is likely to hold a significant revenue share in 2022. In the following years, it is predicted to increase rapidly due to the increasing number of cancer patients in this region. North America dominates the global cytotoxic drugs market due to innovative product developments, the high adoption rate of new therapies, and major market players in this region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The cytotoxic drugs market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Cytotoxic Drugs Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022.

 

The cytotoxic drugs market is poised to grow at a significant CAGR of 2.2% from 2022 to 2028.

 

The leading players in the global cytotoxic drugs market are Pfizer Inc., AbbVie Inc., Johnson & Johnson, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Merck & Co. Inc., Sanofi, Novartis AG, Eli Lilly and Company, and Amgen.

Historic years considered for the market study are 2017 through 2021, 2021 is considered the base year for market estimation, and Seven years forecast presented from 2022 – 2028.

 

 

North America is dominating the global cytotoxic drugs market.

The fastest-growing segment of the global cytotoxic drugs market is antimetabolite drugs.


Report

Table Of Content

1. Executive Summary
2. Global Cytotoxic Drug Market Introduction
2.1. Global Cytotoxic Drug Market – Taxonomy
2.2. Global Cytotoxic Drug Market –Definitions
2.2.1. By Product Type
2.2.2. By Route of Administration
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global Cytotoxic Drug Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cytotoxic Drug Market Dynamic Factors – Impact Analysis
3.6. Global Cytotoxic Drug Market – Competition Landscape
3.7. Epidemiology
4. Global Cytotoxic Drug Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cytotoxic Drug Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Alkylating Agents
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antitumor Antibiotics
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antimetabolites
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Plant Alkaloids
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Cytotoxic Drug Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Oral
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Parental
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Cytotoxic Drug Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Breast Cancer
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Prostate Cancer
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Lung Cancer
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Pancreatic Cancer
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Cytotoxic Drug Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Retail Pharmacy
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospital Pharmacy
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacy
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Cytotoxic Drug Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Cytotoxic Drug Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Application, By End User, and Region, 2022-2028
10. North America Cytotoxic Drug Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Alkylating Agents
10.1.2. Antitumor Antibiotics
10.1.3. Antimetabolites
10.1.4. Plant Alkaloids
10.1.5. Others
10.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Oral
10.2.2. Parental
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Breast Cancer
10.3.2. Prostate Cancer
10.3.3. Lung Cancer
10.3.4. Pancreatic Cancer
10.3.5. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Retail Pharmacy
10.4.2. Hospital Pharmacy
10.4.3. Online Pharmacy
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Cytotoxic Drug Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Application, By End User, and Country, 2022-2028
10.7. North America Cytotoxic Drug Market Dynamics – Trends
11. Europe Cytotoxic Drug Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Alkylating Agents
11.1.2. Antitumor Antibiotics
11.1.3. Antimetabolites
11.1.4. Plant Alkaloids
11.1.5. Others
11.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Oral
11.2.2. Parental
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Breast Cancer
11.3.2. Prostate Cancer
11.3.3. Lung Cancer
11.3.4. Pancreatic Cancer
11.3.5. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Retail Pharmacy
11.4.2. Hospital Pharmacy
11.4.3. Online Pharmacy
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Cytotoxic Drug Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Application, By End User, and Country, 2022-2028
11.7. Europe Cytotoxic Drug Market Dynamics – Trends
12. Asia-Pacific Cytotoxic Drug Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Alkylating Agents
12.1.2. Antitumor Antibiotics
12.1.3. Antimetabolites
12.1.4. Plant Alkaloids
12.1.5. Others
12.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Oral
12.2.2. Parental
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Breast Cancer
12.3.2. Prostate Cancer
12.3.3. Lung Cancer
12.3.4. Pancreatic Cancer
12.3.5. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Retail Pharmacy
12.4.2. Hospital Pharmacy
12.4.3. Online Pharmacy
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Cytotoxic Drug Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Application, By End User, and Country, 2022-2028
12.7. Asia-Pacific Cytotoxic Drug Market Dynamics – Trends
13. Latin America Cytotoxic Drug Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Alkylating Agents
13.1.2. Antitumor Antibiotics
13.1.3. Antimetabolites
13.1.4. Plant Alkaloids
13.1.5. Others
13.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Oral
13.2.2. Parental
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Breast Cancer
13.3.2. Prostate Cancer
13.3.3. Lung Cancer
13.3.4. Pancreatic Cancer
13.3.5. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Retail Pharmacy
13.4.2. Hospital Pharmacy
13.4.3. Online Pharmacy
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Cytotoxic Drug Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Application, By End User, and Country, 2022-2028
13.7. Latin America Cytotoxic Drug Market Dynamics – Trends
14. Middle East and Africa Cytotoxic Drug Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Alkylating Agents
14.1.2. Antitumor Antibiotics
14.1.3. Antimetabolites
14.1.4. Plant Alkaloids
14.1.5. Others
14.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Oral
14.2.2. Parental
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Breast Cancer
14.3.2. Prostate Cancer
14.3.3. Lung Cancer
14.3.4. Pancreatic Cancer
14.3.5. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Retail Pharmacy
14.4.2. Hospital Pharmacy
14.4.3. Online Pharmacy
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Cytotoxic Drug Market – Opportunity Analysis Index, By Product Type, By Route of Administration, By Application, By End User, and Country, 2022-2028
14.7. MEA Cytotoxic Drug Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Product Types, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Pfizer Inc.
15.2.2. AbbVie Inc.
15.2.3. Johnson & Johnson
15.2.4. GlaxoSmithKline PLC
15.2.5. F. Hoffmann-La Roche AG
15.2.6. Bristol-Myers Squibb
15.2.7. Merck & Co. Inc.
15.2.8. Sanofi
15.2.9. Novartis AG
15.2.10. Eli Lilly and Company
15.2.11. Amgen
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Pfizer Inc.
  • AbbVie Inc.
  • Johnson & Johnson
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Bristol-Myers Squibb
  • Merck & Co. Inc.
  • Sanofi
  • Novartis AG
  • Eli Lilly and Company
  • Amgen

Description

Cytotoxic Drugs Market size is expected to be valued at USD 15,927.2 million in 2022, growing at a significant CAGR of 2.2% during 2022–2028. Cytotoxic drugs, also known as antineoplastics, are a group of medicines that contain toxic chemicals to cells, preventing their replication or growth. They are widely used to treat various cancers and other disorders, such as rheumatoid arthritis and multiple sclerosis. Cytotoxic drugs can destroy tumors and reduce metastases and lessen cancer symptoms. Cancer cells replicate faster than normal cells, making them susceptible to cytostatics. The effects on normal cells are less pronounced, and healthy cells recover faster. The increasing prevalence of various types of cancer, such as leukemia, breast cancer, etc, is the major driver in the global cytotoxic drugs market growth. According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The most common cancer in 2020 was breast cancer (2.26 million cases), lung (2.21 million cases), etc. Moreover, increasing use and approval of cytotoxic drugs are also expected to boost the global cytotoxic drugs market growth. Also, the growing therapeutic area of cytotoxic drugs in auto-immune conditions such as rheumatoid arthritis, psoriasis, or prevention of transplant rejection is influencing the overall cytotoxic market growth. However, the adverse side effects of the consumption of cytotoxic drugs, such as nausea and vomiting, severe diarrhea, and damage to normal cells and tissue, are restraining the global cytotoxic drugs market growth. Based on the product type, the global cytotoxic market is segmented into alkylating agents, antitumor antibiotics, antimetabolites, plant alkaloids, and others. The antimetabolites segment held the major global cytotoxic drugs market revenue in 2021. Geographically, North America held the major market share in the global cytotoxic drugs market and is expected to dominate the global market in the forecasted years.

Recent Market Developments:

In Sept 2022, FDA cleared AstraZeneca’s Imfinzi to treat locally advanced or metastatic biliary tract cancer, making it the first immunotherapy-based treatment option for this aggressive cancer type.

In May 2022, Pfizer announced Asia’s first global drug development center at IIT Madras Research Park.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX